These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12007524)

  • 1. Targeting afferent hyperexcitability for therapy of the painful bladder syndrome.
    Yoshimura N; Seki S; Chancellor MB; de Groat WC; Ueda T
    Urology; 2002 May; 59(5 Suppl 1):61-7. PubMed ID: 12007524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid.
    Kirimoto T; Nakano K; Irimura K; Hayashi Y; Matsuura N; Kiniwa M; Oka T; Yoshimura N
    BJU Int; 2007 Oct; 100(4):935-9. PubMed ID: 17714534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical suplatast tosilate (IPD-1151T) inhibits experimental bladder inflammation.
    Boucher W; Kempuraj D; Cao J; Papaliodis D; Theoharides TC
    J Urol; 2007 Mar; 177(3):1186-90. PubMed ID: 17296442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of suplatast tosilate (IPD-1151T) on types I-IV allergic reactions].
    Matsuura N; Mori H; Nagai H; Koda A
    Nihon Yakurigaku Zasshi; 1992 Dec; 100(6):495-501. PubMed ID: 1282894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T.
    Ueda T; Tamaki M; Ogawa O; Yamauchi T; Yoshimura N
    J Urol; 2000 Dec; 164(6):1917-20. PubMed ID: 11061880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide modulates Ca(2+) channels in dorsal root ganglion neurons innervating rat urinary bladder.
    Yoshimura N; Seki S; de Groat WC
    J Neurophysiol; 2001 Jul; 86(1):304-11. PubMed ID: 11431511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kimura's disease associated with bronchial asthma presenting eosinophilia and hyperimmunoglobulinemia E which were attenuated by suplatast tosilate (IPD-1151T).
    Tsukagoshi H; Nagashima M; Horie T; Oyama T; Yoshii A; Sato T; Iizuka K; Dobashi K; Mori M
    Intern Med; 1998 Dec; 37(12):1064-7. PubMed ID: 9932643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of suplatast tosilate (IPD-1151T) on a mouse model of asthma: inhibition of eosinophilic inflammation and bronchial hyperresponsiveness.
    Zhao GD; Yokoyama A; Kohno N; Sakai K; Hamada H; Hiwada K
    Int Arch Allergy Immunol; 2000 Feb; 121(2):116-22. PubMed ID: 10705221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell lines.
    Oda N; Minoguchi K; Yokoe T; Hashimoto T; Wada K; Miyamoto M; Tanaka A; Kohno Y; Adachi M
    Life Sci; 1999; 65(8):763-70. PubMed ID: 10466742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case report of eosinophilic cystitis treated with oral suplatast tosilate].
    Kuramoto T; Senzaki H; Inagaki T
    Hinyokika Kiyo; 2014 Sep; 60(9):447-50. PubMed ID: 25293800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies.
    Furukido K; Takeno S; Ueda T; Hirakawa K; Yajin K
    Am J Rhinol; 2002; 16(6):329-36. PubMed ID: 12512908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of eosinophilic cystitis that was treated with oral suplatast tosilate (IPD-1151T)].
    Watanabe M; Yamaguchi K; Yamanishi T; Kamai T; Yoshida K
    Hinyokika Kiyo; 2009 Nov; 55(11):715-9. PubMed ID: 19946192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
    Yokomura K; Suda T; Matsuda H; Hashizume H; Asada K; Suzuki K; Chida K
    J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. asakazu@med.showa-u.dc.jp.
    Asano K; Mizutani T; Shimane T; Hisano M; Hisamitsu T; Suzaki H
    Mediators Inflamm; 2000; 9(2):77-84. PubMed ID: 10958380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of afferent sensitization in a rat model of cystitis with urothelial barrier dysfunction.
    Montalbetti N; Rooney JG; Rued AC; Carattino MD
    J Neurophysiol; 2019 Sep; 122(3):1136-1146. PubMed ID: 31314637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suplatast tosilate for treating cutaneous mastocytosis.
    Yasudo H; Ando T; Hiwatari M; Oka A
    Pediatr Dermatol; 2015; 32(3):e118-9. PubMed ID: 25779849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an orally active Th2 cytokine inhibitor, suplatast on "atopic cough" tosilate.
    Ishiura Y; Fujimura M; Yamamoto H; Nobata K; Ishiguro T; Ogawa H; Myou S
    Arzneimittelforschung; 2008; 58(6):297-302. PubMed ID: 18677972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
    Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
    Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effect of IPD-1151T (suplatast tosilate) on mast cell induction from normal mouse spleen cells].
    Kouno S; Adachi M; Asano K; Okamoto K; Takahashi T
    Arerugi; 1992 Oct; 41(10):1488-91. PubMed ID: 1336362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.